IFIT2 and intrahepatic cholangiocarcinoma: Kaplan–Meier analysis revealed that ICC patients with low IFIT2 expression had poorer DFS (P = 0.0032, Fig. 5I) and OS (P = 0.0321, Fig. 5J).